Time course of cell cycle-related protein expression in diethylnitrosamine-initiated rat liver

Journal of Hepatology

Volumn 29, Issue 3, 1998, Pages 464-469

  Lee, Yun Sil ^a   Kim, Woo Ho ^b   Yu, Eun Sil ^a   Kim, Mee Rhan ^b   Lee, Min Jae ^b   Jang, Ja June ^b  

^a University of Ulsan   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Cell cycle related proteins; Diethylnitrosamine; Initiative liver; Rats; Time course

Indexed keywords

CELL CYCLE PROTEIN; DIETHYLNITROSAMINE; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; LIVER CANCER; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; TIME;

EID: 0032171327     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80066-4     Document Type: Article

References (27)

1. Bannasch P, Meyer D, Hacker HJ. Hepatocellular glycogenesis and hepatocarcinogenesis. Biochim Biophys Acta. 605:1980;217-245.
2. Emmelot P, Scherer E. The first relevant cell stage in rat liver carcinogenesis: a quantitative approach. Biochim Biophys Acta. 605:1980;247-304.
3. Schere E, Emmelot P. Kinetics of induction and growth of precancerous liver-cell foci and liver tumor formation by diethylnitrosamine in the rat. Eur J Cancer. 11:1975;689-696.
4. Goldworthy TL, Pitot HC. An approach to the development of a short-term whole animal bioassay to distinguish initiating agents, promoting agents, complete carcinogens, and noncarcinogens in rat liver. J Toxicol Environ Health. 16:1985;389-402.
5. Emmelot P, Scherer E. The first relevant cell stage in rat liver carcinogenesis. A quantitative approach. Biochim Biophys Acta. 605:1980;247-304.
6. Cameron R. Identification of the putative first cellular step of chemical hepatocarcinogenesis. Cancer Lett. 47:1989;163-167.
7. Pitot H, Campbell H, Marompot R, Bawa N, Rizvi T, Xu YH, et al. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol. 17:1989;594-612.
8. Cayama E, Tsuda H, Sarma DSR, Farber E. Initiation of liver carcinogenesis requires cell proliferation. Nature. 275:1978;60-61.
9. Columbano A, Rajalakshmi S, Sarma DSR. Requirements of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res. 41:1981;2079-2083.
10. Murray AW. Creative blocks: cell-cycle checkpoints and feedback controls. Nature. 359:1992;599-604.
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Paarsons R, Trent JM, et al. Waf1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
12. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA. 91:1994;709-713.
13. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman S, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
14. Goldsworthy TL, Goldsworthy SM, Sprankle CS, Butterworth BE. Expression of myc, fos and Ha-ras associated with chemically induced cell proliferation in the rat liver. Cell Prolif. 27:1994;269-278.
15. Rininger JA, Goldsworthy TL, Babish JG. Time course comparison of cell-cycle protein expression following partial hepatectomy and WY14,463-induced hepatic cell proliferation in F344 rats. Carcinogenesis. 18:1997;935-941.
16. Pines J. The cell cycle kinases. Semin Cancer Biol. 5:1994;305-313.
17. Ando K, Griffin JD. CDK4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Oncogene. 10:1995;751-755.
18. Denova M, Giordano M, Mazzini G, Riccardi A. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk Res. 14:1990;417-422.
19. Mosner J, Deppert W. p53 and mdm2 are expressed independently during cellular proliferation. Oncogene. 9:1994;3321-3328.
20. Kemp CJ. Hepatocarcinogenesis in p53-deficient mice. Mol Carcinogenesis. 12:1995;132-221.
21. Deppert W, Buschhausen-Denker G, Patschinsky T, Steinmeyer K. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression. Oncogene. 5:1990;1701-1706.
22. Shohat O, Greenberg M, Reisman D, Oren M, Rotter V. Inhibition of cell growth mediated by plasmids encoding p53 antisense. Oncogene. 1:1987;277-283.
23. Kip1 accumulation during the cell cycle. Science. 271:1996;1861-1864.
24. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
25. El-Deiry WAS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated GI arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
26. Steinmann KE, Pei XF, Stoppler H, Schlegel R. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. Oncogene. 9:1994;387-394.
27. Wolowiec D, Deviller P, Simonin D, Souchier C, Rimokh R, Benchaib M, et al. CDK1 is a marker of proliferation in human lymphoid cells. Int J Cancer. 61:1995;381-388.